The Global Cancer Coalitions Network hosted its second “Coalition Connection 2: COVID19 Vaccines & Cancer” virtual event on November 23. The event was moderated by Alex Filicevas, Executive Director of the World Bladder Cancer Patient Coalition.
Formed in the wake of COVID-19, the Global Cancer Coalition Network is a collaboration of nine global cancer coalitions and alliances, representing 750 patient organisations working on behalf of 14 million cancer patients around the world.
The World Bladder Cancer Patient Coalition (WBCPC) joined two separate panel discussions at The Economist’s 7th Annual World Cancer Series: Europe which took place virtually on November 8-11, 2021.
The 7th World Cancer Series: Europe 2021 explored what needs to be done to catalyse a “triple bottom line” for Europe: better cancer outcomes, sustainable cancer care, and social and economic growth and development. And how this can impact cancer care beyond the region.
English:
Today, we launch the third language with our global bladder cancer patient experience survey in French! This is an important step in the need to address the global evidence gap relating to the experiences of bladder cancer patients and carers.
The survey aims to capture the experiences of bladder cancer patients and caregivers around the world. Patient and carer experience data help to identify what is important to them, and in turn,
After spending 2020 at a distance, the 41st Société Internationale d’Urologie (SIU) Annual Congress is being held in conjunction with the 10th Emirates International Urological Conference of the Emirates Urological Society (EUS) during November 10-14 in Dubai, United Arab Emirates.
Join us in Dubai as the World Bladder Cancer Patient Coalition (WBCPC) in the Exhibit Hall at booth 520. Dr Lydia Makaroff, President and Alex Filicevas,
The Economist’s 7th Annual World Cancer Series: Europe will convene 2000+ policymakers, health-care providers, industry, and patient groups for robust debate and dialogue.
The faculty of experts will explore not only what can be done to improve cancer control, but why this is urgent.
What are the real-world examples of improved care for the individual with (or at risk of) cancer? How does improving care and patient health across the region contribute to social and economic development across Europe?
The World Bladder Cancer Patient Coalition (WBCPC) was pleased to be present at Global Congress on Bladder Cancer 2021 on October 14-15 in Ghent (Belgium). It was also the first time WBCPC was participating at an event in-person since 2019. The theme and focus of the congress this year was turning new data into daily practices. The program consisted of state-of-the-art lectures, case discussions, and panel debates with international & multidisciplinary experts, including a session with bladder cancer patients and patient representatives.
The Global Cancer Coalitions Network (GCCN) is hosting a virtual event on November 23, at 13:00 CEST, titled “Coalition Connection 2: COVID19 Vaccines & Cancer”. A free online event that will cover the challenges that the COVID19 vaccine rollout has presented, not least for those already coping with a cancer diagnosis.
This event will be moderated by Alex Filicevas, Executive Director of WBCPC and it will seek to answer your potential questions from the perspectives of an Immunologist,
The findings will fill a critical evidence gap, on patient and carer experiences and guide our future work.
This survey is now closed.
We are proud to launch the first-ever global bladder cancer patient and carer experience survey, in partnership with our 11 member organisations.
Globally there are over 570,000 people newly diagnosed with bladder cancer each year, and 1.7 million people currently living with this disease.
The Advocacy Exchange, a virtual platform created by Bristol Myers Squibb (BMS) and GRYT Health, unites advocacy organizations, patients, and members of the healthcare industry by sharing resources and best practices.
The upcoming discussion on this virtual platform is taking place on September 30, at 12:00 pm (ET), titled: “Giving Voice to the Often Voiceless: Advocate-led Research Creating Change” and Alex Filicevas, WBCPC Executive Director is invited and will be representing the voice of patients.